Condition

Juvenile Idiopathic Arthritis

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 20 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials20

Recruiting2

Common interventions25

Lead sponsors shown15

Clinical trials

20 shown

Health and Exercise Response in Children With Chronic and Auto-immune PathologiesNCT03913962 · 2019-05-02

Medical Follow-up of New Cases of Polyarthritis in Children and Young AdultsNCT07000916 · 2013-09-11

Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With ArthritisNCT04585711 · 2026-07-01

Mesenchymal Stem Cells Infusion in Patients With Autoimmune DiseasesNCT06888973 · 2025-02-01

ENROLLING_BY_INVITATION

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic DiseasesNCT05879419 · 2023-05-23

ACTIVE_NOT_RECRUITING

Transition to Adulthood Through Coaching and Empowerment in RheumatologyNCT05545839 · 2022-10-17

Host-microbiota-environment InteractionsNCT05176795 · 2022-03-16

Effectiveness and Feasibility of a Home-based Exercise Program for Adolescents With Juvenile Idiopathic ArthritisNCT05114343 · 2021-12-01

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and InflammationNCT04902807 · 2021-09-07

Genicular Nerve Block in Juvenile Idiopathic ArthritisNCT04687930 · 2020-12-01

Yellow Fever Vaccine in Patients With Rheumatic DiseasesNCT03430388 · 2018-01-31

Treatment Tapering in JIA With Inactive DiseaseNCT02840175 · 2017-05-18

PatientSpot Formerly Known as ArthritisPowerNCT03840928 · 2015-04-01

Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis PatientsNCT02116504 · 2014-04-01

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFαNCT01694264 · 2012-09-01

Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesNCT01151644 · 2010-04-01

Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young AdultsNCT00534495 · 2008-11-01

Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic ArthritisNCT00443430 · 2007-05-01

PEAK Study (Physical Exercise and Activity in Kids)NCT00213187 · 2002-08-01

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)NCT02784808 · 2000-01-01

Common interventions

Leading sponsors

University of Sao Paulo General Hospital 3 Assistance Publique - Hôpitaux de Paris 2 University Hospital, Clermont-Ferrand 2 Duke University 1 Global Healthy Living Foundation 1 Hoffmann-La Roche 1 Institut National de la Santé Et de la Recherche Médicale, France 1 McMaster University 1 Montefiore Medical Center 1 National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 1 Seattle Children's Hospital 1 Seoul National University Hospital 1 Sohag University 1 The Hospital for Sick Children 1 Université Catholique de Louvain 1

Trial status mix

COMPLETED9

UNKNOWN4

RECRUITING2

TERMINATED2

ACTIVE_NOT_RECRUITING1

ENROLLING_BY_INVITATION1

WITHDRAWN1

Phase mix

NA5

PHASE44

PHASE23

PHASE12

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.